The civic record
Read. Follow. Verify.Colorado regulates sales and safety of compounded GLP-1 weight-loss drugs
Last action · May 5, 2026: House Committee on Health & Human Services Postpone IndefinitelySponsors: John Carson and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Colorado sets new safety, labeling, advertising, and record-keeping rules for sellers and distributors of compounded GLP-1 weight-loss medications. Under the measure, sellers must verify FDA-compliant sourcing and manufacturing, include explicit warning labels, and maintain distribution records for two years after expiration. Violations can lead to fines of up to $1,000 per dose by the state board of pharmacy and enforcement by the attorney general as deceptive trade practices.
Sellers and distributors of custom weight-loss drugs face strict verification and record-keeping obligations, while patients receiving these prescriptions must receive specific safety disclosures and warning labels.
- Compounded medications are custom mixtures created by pharmacies to meet individual patient needs when commercial drugs are unavailable or require specific alterations. context
- GLP-1 receptor agonists have seen a dramatic surge in demand for obesity treatment and weight management. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
sellers and distributors of compounded weight-loss medications
Sellers and distributors must comply with FDA-related verification rules, warning label requirements, record-keeping mandates, and face potential fines or license revocation for violations.
patients prescribed compounded weight-loss medications
Patients must receive specific disclosures when prescribed these medications and will see mandatory safety warnings on product labels.
state board of pharmacy
The board gains the authority to inspect records, issue fines of up to $1,000 per dose, and revoke business or pharmacy licenses for non-compliance.
attorney general
The attorney general receives exclusive authority to enforce violations of the bill as deceptive trade practices under the Colorado Consumer Protection Act.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What warnings must appear on compounded weight-loss medications?
Who can enforce the requirements of this bill?
Are all medical facilities subject to these rules?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed chamber. The next step in the legislative lifecycle is Law.
Procedural history
22 actions- May 5, 2026HouseHouse Committee on Health & Human Services Postpone Indefinitely
- Apr 20, 2026HouseIntroducedIntroduced In House - Assigned to Health & Human Services
- Apr 17, 2026SenateFloorSenate Third Reading Passed with Amendments - Floor
- Apr 10, 2026SenateSenate Third Reading Laid Over to 04/17/2026 - No Amendments
- Apr 9, 2026SenateSenate Third Reading Laid Over to 04/10/2026 - No Amendments
- Apr 8, 2026SenateSenate Third Reading Laid Over to 04/09/2026 - No Amendments
Show 16 earlier actions
- Apr 7, 2026SenateSenate Third Reading Laid Over to 04/08/2026 - No Amendments
- Apr 6, 2026SenateSenate Third Reading Laid Over to 04/07/2026 - No Amendments
- Mar 30, 2026SenateSenate Third Reading Laid Over to 04/06/2026 - No Amendments
- Mar 27, 2026SenateSenate Third Reading Laid Over to 03/30/2026 - No Amendments
- Mar 26, 2026SenateSenate Third Reading Laid Over to 03/27/2026 - No Amendments
- Mar 25, 2026SenateSenate Third Reading Laid Over to 03/26/2026 - No Amendments
- Mar 24, 2026SenateSenate Third Reading Laid Over to 03/25/2026 - No Amendments
- Mar 23, 2026SenateSenate Third Reading Laid Over to 03/24/2026 - No Amendments
- Mar 20, 2026SenateSenate Third Reading Laid Over to 03/23/2026 - No Amendments
- Mar 19, 2026SenateSenate Third Reading Laid Over to 03/20/2026 - No Amendments
- Mar 18, 2026SenateSenate Third Reading Laid Over to 03/19/2026 - No Amendments
- Mar 17, 2026SenateSenate Third Reading Laid Over to 03/18/2026 - No Amendments
- Mar 16, 2026SenateFloorSenate Second Reading Passed with Amendments - Committee, Floor
- Mar 10, 2026SenateSenate Second Reading Laid Over to 03/16/2026 - No Amendments
- Mar 5, 2026SenateCommitteeSenate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
- Jan 28, 2026SenateIntroducedIntroduced In Senate - Assigned to Health & Human Services
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Voting Record
Postpone Senate Bill 26-066 indefinitely.
Total
7
- Yes
- 7
- No
- 0
- Present
- 0
- Not voting
- 0
- Abstain
- 0
Show 1 earlier roll call
Refer Senate Bill 26-066, as amended, to the Committee of the Whole.
Total
9
- Yes
- 5
- No
- 4
- Present
- 0
- Not voting
- 0
- Abstain
- 0
How they voted (9)
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Exclusive Enforcement by Attorney General
The legislation explicitly bars private lawsuits and grants exclusive enforcement authority to the attorney general under the Colorado Consumer Protection Act.
Connected Entities
Sources
leg.colorado.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy60Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz50Current news / social attention level
Publisher tools